A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection
Abstract HIV infection affects 37 million people and about 1.7 million are infected annually. Among the phase III clinical trials only the RV144 vaccine trial elicited significant protection against HIV-1 acquisition, but the efficacy and immune memory were inadequate. To boost these vaccine functio...
Guardado en:
Autores principales: | Yufei Wang, Trevor Whittall, Stuart Neil, Gary Britton, Mukesh Mistry, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Jaranit Kaewkungwal, Sorachai Nitayaphan, Xuesong Yu, Alicia Sato, Robert J. O’Connell, Nelson L. Michael, Merlin L. Robb, Jerome H. Kim, Thomas Lehner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe03733a163a4761833618d8fb3d76d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection.
por: Susan Zolla-Pazner, et al.
Publicado: (2014) -
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1
por: Shida Shangguan, et al.
Publicado: (2021) -
The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques.
por: Yufei Wang, et al.
Publicado: (2012) -
AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
por: Stephen J Kent, et al.
Publicado: (2010) -
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine
por: Slim Fourati, et al.
Publicado: (2019)